MarketScreener Homepage > Equities > Tokyo Stock Exchange > Takeda Pharmaceutical Company Limited 4502 JP3463000004

Report

End-of-day quote Tokyo Stock Exchange - 10/30
3239	JPY		-5.87%

10/30

GLOBAL MARKETS LIVE : Alphabet, Amazon, Starbucks…

10/30

TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience, Confirms Full-Year Management Guidance and Raises Forecasts for Free Cash Flow, Reported OP and Reported EPS

10/30

TAKEDA PHARMACEUTICAL : Notice of the Revised Forecast of Consolidated Financials for FY2020

News

Press Releases

Official Publications

Sector news

MarketScreener Strategies

Analyst Recommendations

Communiqués de presse de la société TAKEDA PHARMACEUTICAL COMPANY LIMITED

10/30	TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience, Conf..	AQ
10/30	TAKEDA PHARMACEUTICAL : Notice of the Revised Forecast of Consolidated Financial..	AQ
10/30	Takeda Expands COVID-19 Vaccine Supply in Japan through Partnership with Mode..	AQ
10/29	MORGAN STANLEY : rates CSL as Equal-weight	AQ
10/29	UPDATE2 : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021	AQ
10/29	UPDATE1 : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021	AQ
10/29	URGENT : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021	AQ
10/29	TAKEDA PHARMACEUTICAL : Urgent Headline News	AQ
10/29	TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience; Conf..	BU
10/29	TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience; Conf..	PU
10/29	TAKEDA PHARMACEUTICAL COMPANY LIMITE : Notice of the Revised Forecast of Consoli..	EQ
10/29	TAKEDA PHARMACEUTICAL : Expands COVID-19 Vaccine Supply in Japan Through Partner..	BU
10/28	TAKEDA PHARMACEUTICAL : to Present Rare Bleeding Disorders Research at Thrombosi..	AQ
10/28	Ono and Takeda Submit Supplemental Application for Opdivo and CABOMETYX Combi..	AQ
10/28	Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMET..	AQ
10/27	TAKEDA PHARMACEUTICAL : Presents Rare Bleeding Disorders Research at Thrombosis ..	BU
10/21	TAKEDA PHARMACEUTICAL : BioLife Plasma Services Announces Opening of First Plasm..	BU
10/14	TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..	AQ
10/13	TAKEDA PHARMACEUTICAL : - Safety and Efficacy of Subcutaneous Entyvio Sustained ..	AQ
10/13	TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..	AQ
10/13	TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..	BU
10/12	TAKEDA PHARMACEUTICAL : Safety and Efficacy of Subcutaneous Entyvio® (Vedolizuma..	BU
10/08	TAKEDA PHARMACEUTICAL : First Patient Enrolled in NIH Phase 3 Trial to Evaluate ..	PU
10/08	TAKEDA PHARMACEUTICAL : and Arrowhead Collaborate to Co-Develop and Co-Commercia..	PU
10/08	TAKEDA PHARMACEUTICAL : and Arrowhead Collaborate to Co-Develop and Co-Commercia..	BU
09/25	TAKEDA PHARMACEUTICAL : Announcement of decision on a basic plan for a merger wi..	AQ
09/24	TAKEDA PHARMACEUTICAL : phRMA - Coming together to fight COVID-19, A conversatio..	AQ
09/24	TAKEDA PHARMACEUTICAL : Announcement of decision on a basic plan for a merger (s..	PU
09/18	FOUNDATION MEDICINE : and Takeda Announce Collaboration To Develop FoundationOne..	BU
09/18	TAKEDA PHARMACEUTICAL : Presents New Data Highlighting Scientific Advancements i..	BU
09/17	PODCAST : Women @ RopesTalk: Conversation With Chika Hirata, Takeda Japan	AQ
09/17	TAKEDA PHARMACEUTICAL : to Divest TachoSil to Corza Health for EUR350 Million	AQ
09/16	TAKEDA PHARMACEUTICAL : Opens New R&D Cell Therapy Manufacturing Facility to Sup..	AQ
09/16	TAKEDA PHARMACEUTICAL : to Divest TachoSil® to Corza Health for €350 Million	BU
09/15	Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources O..	AQ
09/15	TAKEDA PHARMACEUTICAL : Opens New R&D Cell Therapy Manufacturing Facility to Sup..	BU
09/15	TAKEDA PHARMACEUTICAL : European Medicines Agency Approves Label Update for HYQV..	BU
09/11	BIOLIFE PLASMA SERVICES : Announces Opening of First Plasma Collection Center in..	BU
09/10	Chugai and Takeda to Join a Clinical Collaboration for Global Phase III Studi..	AQ
09/10	TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..	AQ
09/09	TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..	PU
09/09	TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..	BU
09/09	TAKEDA PHARMACEUTICAL : Divests Select Non-Core Assets in Europe to Cheplapharm ..	AQ
09/08	TAKEDA PHARMACEUTICAL : Divests Select Non-Core Assets in Europe to Cheplapharm ..	BU
09/03	BLACKSTONE : aims for Takeda OTC drug unit to go public within 10 yrs	AQ
09/02	TAKEDA PHARMACEUTICAL : - Update on the U.S. Development Program for the Investi..	AQ
09/01	TAKEDA PHARMACEUTICAL : Update on the U.S. Development Program for the Investiga..	PU
08/31	MODERNA : Confirms Discussions with the Ministry of Health, Labour and Welfare t..	AQ
08/26	TAKEDA PHARMACEUTICAL : Phase 2 ELEKTRA Study of Soticlestat Meets Primary Endpo..	AQ
08/26	TAKEDA PHARMACEUTICAL : Phase 2 ELEKTRA Study of Soticlestat Meets Primary Endpo..	AQ
08/25	Exelixis Announces Submission of Supplemental New Drug Application to U.S. Fo..	AQ
08/24	TAKEDA PHARMACEUTICAL : Japan's Takeda sells drugs subsidiary to US Blackstone f..	AQ
08/24	TAKEDA PHARMACEUTICAL : to Divest its Japan Consumer Health Care Business Unit t..	PU
08/24	TAKEDA PHARMACEUTICAL COMPANY LIMITE : Takeda to Divest its Japan Consumer Healt..	EQ
08/24	TAKEDA PHARMACEUTICAL : to Divest its Japan Consumer Health Care Business Unit t..	PU
08/18	UNLIKELY TO SUCCEED : Preliminary Injunction Denied Despite Stipulation To Irrep..	AQ
08/10	TAKEDA PHARMACEUTICAL : National Hemophilia Foundation and Takeda Partner with A..	BU
08/10	NOVAVAX : and Takeda Announce Collaboration for Novavax COVID-19 Vaccine Candida..	AQ
08/07	TAKEDA PHARMACEUTICAL : to supply Novavax's coronavirus vaccine candidate in Jap..	AQ
08/07	TAKEDA PHARMACEUTICAL : Novavax and Takeda Announce Collaboration for Novavax' C..	PU
08/07	TAKEDA PHARMACEUTICAL : Novavax and Takeda Announce Collaboration for Novavax' C..	PU
08/06	TAKEDA PHARMACEUTICAL : BioLife Plasma Services Announces Opening of First Plasm..	BU
08/03	TAKEDA PHARMACEUTICAL : Announces FY2020 Q1 Results, Confirms Management Guidanc..	AQ
08/03	TAKEDA PHARMACEUTICAL : Notice of the Revised Forecast of Consolidated Financial..	AQ
08/03	TAKEDA PHARMACEUTICAL : Announces Support for People Affected by 2020 Torrential..	AQ
08/03	TAKEDA PHARMACEUTICAL : Announcement of a merger (simple merger/short-form merge..	PU
08/03	TAKEDA PHARMACEUTICAL : Announcement of a merger (simple merger/short-form merge..	PU
08/01	TAKEDA PHARMACEUTICAL : to Present Rare Bleeding Disorders Research Highlighting..	BU
07/31	TAKEDA PHARMACEUTICAL : Announces U.S. FDA Breakthrough Therapy Designation Gran..	AQ
07/31	TAKEDA PHARMACEUTICAL : Summary of Financial Statements for the Three-month Peri..	PU
07/31	TAKEDA PHARMACEUTICAL : Announces FY2020 Q1 Results; Confirms Management Guidanc..	PU
07/31	TAKEDA PHARMACEUTICAL COMPANY LIMITE : Notice of the Revised Forecast of Consoli..	EQ
07/31	TAKEDA PHARMACEUTICAL : Announces Support for People Affected by 2020 Torrential..	PU
07/30	TAKEDA PHARMACEUTICAL : Announces U.S. FDA Breakthrough Therapy Designation Gran..	BU
07/12	TAKEDA PHARMACEUTICAL : Provides Updates on Its Pharmacokinetic-guided Prophylax..	BU

1 2 3 4 5 6 7 8 9 10 Next

Analysis

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone